ASX:ASB
ASX:ASBAerospace & Defense

Austal’s Raised FY2025 Earnings Guidance Might Change The Case For Investing In Austal (ASX:ASB)

On August 4, 2025, Austal Limited announced that it had increased its unaudited FY2025 EBIT guidance, lifting its minimum target from at least A$80 million to at least A$100 million. This marks a significant uplift in management expectations, reflecting optimism around improving operational performance and future earnings potential. We'll explore how this raised earnings guidance could influence Austal's investment narrative, especially with respect to future revenue confidence. Rare earth...
ASX:QBE
ASX:QBEInsurance

QBE Insurance Group (ASX:QBE) Is Down 6.7% After Profits Rise but Revenue Outlook Disappoints

QBE Insurance Group reported half-year earnings as of June 30, 2025, with net income rising to US$1.02 billion from US$802 million a year earlier and earnings per share also increasing. However, while profitability improved, the company missed revenue estimates and flagged the likelihood of declining annual revenues, prompting analysts to caution about the effects of lower interest rates on future performance. We'll explore how QBE's improved profit margins but softer revenue outlook may...
ASX:PNI
ASX:PNICapital Markets

How Investors Are Reacting To Pinnacle Investment Management Group (ASX:PNI) Dividend Lift and Profit Growth

Pinnacle Investment Management Group announced an ordinary dividend of A$0.27 per share for the six months ended June 30, 2025, following its report of full year results showing sales of A$65.48 million and net income of A$134.43 million, both increasing from the prior year. This combination of higher earnings and an increased dividend suggests the company is translating its recent growth into greater tangible returns for shareholders. We'll explore how Pinnacle's stronger profitability and...
ASX:CSL
ASX:CSLBiotechs

How Investors May Respond To CSL (ASX:CSL) Gaining Canadian Approval for ANDEMBRY in Rare Disease Market

CSL recently announced that Health Canada granted marketing authorization for ANDEMBRY (garadacimab), a monoclonal antibody for the routine prevention of hereditary angioedema attacks in patients aged 12 years and older. This regulatory milestone gives CSL access to the Canadian HAE market with a product that showed very large reductions in attack frequency and sustained safety in pivotal studies. We'll examine how ANDEMBRY's approval in Canada could strengthen CSL's position and growth...
ASX:CNI
ASX:CNIREITs

How Investors May Respond To Centuria Capital Group (ASX:CNI) Acquiring Port Adelaide Distribution Centre Below Replacement Cost

Centuria Capital Group recently acquired the Port Adelaide Distribution Centre in South Australia for A$216 million, approximately 70% below its replacement cost, and established the Centuria Port Adelaide Industrial Fund to offer this major industrial estate to retail, wholesale, and institutional investors. This acquisition not only secures a significant industrial asset with strong occupancy and high-quality tenants, but also positions Centuria for potential growth linked to surrounding...
ASX:IAG
ASX:IAGInsurance

Profit Surge and New Royal Auto Club Alliances Could Be a Game Changer for Insurance Australia Group (ASX:IAG)

Insurance Australia Group released its full-year 2025 results, reporting net income of A$1.36 billion, a 51% increase from the prior year, and raising its dividend by 15% following higher premiums and lower natural peril costs. An important development is the company’s new alliances with the Royal Automobile Clubs of Queensland and Western Australia, which are expected to add around A$3 billion in gross written premium and boost future insurance profit by at least A$300 million after full...
ASX:CLW
ASX:CLWREITs

Charter Hall Long WALE REIT (ASX:CLW) Is Up 6.2% After Returning to Profitability and Confirming Guidance – What's Changed

Charter Hall Long WALE REIT recently reported its full year results for June 2025, showing a return to profitability with A$346.9 million in revenue and net income of A$118.28 million, and confirmed operating earnings and distribution guidance of 25.5 cents per security for the upcoming year. This marks a turnaround from the previous year’s loss, with management signalling confidence through both earnings and distribution outlook for fiscal 2026. Given the company's improved profitability...
ASX:WGX
ASX:WGXMetals and Mining

Westgold Resources (ASX:WGX) Is Up 12.9% After Unveiling A$50 Million Exploration Investment and 2026 Guidance

Westgold Resources recently announced plans to invest A$50 million in exploration and resource definition across its Murchison and Southern Goldfields sites, while also issuing group production guidance for 2026 targeting 345,000 to 385,000 ounces, including output from third-party ore. This commitment to increased exploration activity alongside a higher production outlook underscores management’s confidence in expanding resource potential and scaling operations for future growth. We'll look...
ASX:CGS
ASX:CGSHealthcare Services

3 ASX Penny Stocks With Market Caps Larger Than A$80M

Australian shares are experiencing a positive trend, with the ASX 200 climbing towards new all-time highs, buoyed by recent decisions from the Reserve Bank. In such an encouraging market environment, identifying stocks that balance affordability with growth potential is key. While 'penny stocks' might seem like a term from another era, they remain relevant for investors seeking opportunities in smaller companies with solid financial foundations and promising prospects.